Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05531643
NA

Pilot Study of TENS for Ocular Pain

Sponsor: VA Office of Research and Development

View on ClinicalTrials.gov

Summary

Approximately 20% of Veterans have a diagnosis of dry eye (DE) syndrome which is often accompanied by ocular pain that significantly impacts activities of daily living. Currently very few treatments are available for chronic ocular pain, likely because the mechanisms underlying this type of pain have only recently begun to be studied. New treatments that target the neuropathic mechanisms contributing to this type of pain are needed. The proposed research provides a crucial step in addressing the lack of treatments for neuropathic ocular pain by validating the methodology needed to support a randomized controlled trial of transcutaneous electrical nerve stimulation (TENS). TENS is a non-pharmacologic, non-addictive, non-invasive treatment that has been shown to be effective in other chronic pain conditions. The present pilot study aims to address the need for preliminary support of safety and efficacy of TENS for ocular pain, t to advance the study of new treatments for the long-term relief of chronic ocular pain and its impact on health.

Official title: A Pilot Study of the Safety and Feasibility of Transcutaneous Electrical Nerve Stimulation (TENS) for Chronic Ocular Pain

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

39

Start Date

2022-10-03

Completion Date

2024-11-30

Last Updated

2026-06-10

Healthy Volunteers

No

Conditions

Interventions

DEVICE

High frequency forehead TENS

Transcutaneous electrical nerve stimulation (TENS) device with electrode placement at the forehead. Biphasic rectangular impulses at 60Hz frequency will be delivered for a maximum of 20 minutes at a maximum amplitude of 16mA. Participant may halt amplitude before it reaches maximum amplitude. The device has previously been cleared by the FDA for use in migraine patients.

DEVICE

Low frequency forehead TENS

Transcutaneous electrical nerve stimulation (TENS) device with electrode placement at the forehead. A 3Hz biphasic square wave will be delivered for 20 minutes up to a maximum amplitude of 16mA.

Locations (1)

Miami VA Healthcare System, Miami, FL

Miami, Florida, United States